Joshua Sharfstein, the Obama administration’s nominee for the No. 2 job at the FDA, will become acting chief of the agency on Monday, according to media reports. Here’s a news alert from InsideHealthPolicy.com “Joshua Sharfstein, selected by the White House for the No. 2 job at FDA, will take over Monday as acting commissioner. […]
The benefits of early anti-HIV therapy for patients with an opportunistic infection outweigh the risks, according to new guidelines from the CDC. The guidelines, developed with the NIH and the Infectious Diseases Society of America, say that for most such infections, early antiretroviral therapy will lead to better outcomes. One exception, however, is tuberculosis. […]
Some of the greatest minds on TB gathered this week here in Rio de Janeiro, Brazil, where advocates, researchers, and donors from all over the world attended the Stop TB Partnership. TB is killing nearly 2 million people a year, yet still gets far too little attention, and the purpose of the conference was to […]
HIV
Progress seen in recent years against the HIV pandemic, including in rising numbers of people diagnosed and treated accompanied by dropping rates of incidence and death, […]
Tuberculosis
SYDNEY – When Merinda Sebayang was undergoing treatment for multidrug-resistant TB in Indonesia – a nation with the third highest tuberculosis burden in the world after […]
Research & Development
A randomized, multi-country clinical trial testing a regimen for treating drug-resistant tuberculosis in less than a year against the up to two-year regimen recommended by the […]
Policy
With a report showing that 2018 yielded the highest case numbers seen so far of a paralyzing condition largely among children who had been sick with […]